Canada markets closed

Tryp Therapeutics Inc. (TRYPF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0562+0.0137 (+32.24%)
At close: 03:17PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.23M
Enterprise Value 6.39M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)9.14
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.57

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-19.48%
S&P500 52-Week Change 323.57%
52 Week High 30.0919
52 Week Low 30.0041
50-Day Moving Average 30.0248
200-Day Moving Average 30.0385

Share Statistics

Avg Vol (3 month) 344.71k
Avg Vol (10 day) 376.12k
Shares Outstanding 596.42M
Implied Shares Outstanding 699.59M
Float 8154.01M
% Held by Insiders 10.70%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Aug 31, 2023
Most Recent Quarter (mrq)Feb 29, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-55.90%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-2.95M
Diluted EPS (ttm)-0.0300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.26M
Total Cash Per Share (mrq)0
Total Debt (mrq)15.92M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.08
Book Value Per Share (mrq)-0.06

Cash Flow Statement

Operating Cash Flow (ttm)-6.22M
Levered Free Cash Flow (ttm)46.21k